The Effect of Breathing Exercise on Fatigue in Heart Failure Patients
NCT ID: NCT05129371
Last Updated: 2024-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2020-03-18
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breathing Relaxation Exercise Heart Failure
NCT05905627
Effects of a 20-Minute Mindfulness-Based Breathing Exercise on Dyspnea, Fatigue, and Sleep Quality in Patients With Heart Failure
NCT07046091
Physical Activity Program on Clinical Output in Heart Failure
NCT05349786
Ventilatory Support Associated With Exercise in Heart Failure
NCT02384798
Aerobic Training and Cardiopulmonary Responses In Heart Failure
NCT07128784
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathing Exercise Group
This group will be given breathing exercises in accordance with the determined protocol.
Breathing exercise
Following the protocol prepared, the breathing exercise group is given breathing exercises for about 20 minutes, 3 times a week for 8 weeks, under the supervision of the trainer, in the hospital face-to-face, and after discharge through video calls over the WhatsApp application. Reminders (by text message or voice call) are used for the remaining 4 days of the week, allowing the patient to do it on their own.
Placebo Breathing Group
Normal breathing of this group will be monitored.
Placebo Breathing Group
The placebo group is asked to breathe normally through the nose with eyes closed, sitting in the same position as the intervention group for 10-15 minutes, 3 times a week for 8 weeks, under the supervision of the trainer, in the hospital face-to-face, and after discharge through video calls over the WhatsApp application.
Control Group
No application will be made to this group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breathing exercise
Following the protocol prepared, the breathing exercise group is given breathing exercises for about 20 minutes, 3 times a week for 8 weeks, under the supervision of the trainer, in the hospital face-to-face, and after discharge through video calls over the WhatsApp application. Reminders (by text message or voice call) are used for the remaining 4 days of the week, allowing the patient to do it on their own.
Placebo Breathing Group
The placebo group is asked to breathe normally through the nose with eyes closed, sitting in the same position as the intervention group for 10-15 minutes, 3 times a week for 8 weeks, under the supervision of the trainer, in the hospital face-to-face, and after discharge through video calls over the WhatsApp application.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years old and over
* Diagnosed with heart failure at least 6 months ago, according to the heart failure classification of the New York Heart Association (NYHA) II. or III. in phase
* Left ventricular ejection fraction \< 50%
* Volunteer to participate in the research
* Piper fatigue scale score of 4 and above
* Hb value of 8 gm/dL or more
* Having an Internet connection and a smartphone at or near Patients meeting all of the above criteria are included in the study.
Exclusion Criteria
* Having a problem (due to deviation of the septum, etc.) that causes difficulty in doing breathing exercises
* Have a serious mental illness/cognitive problem that may affect their perception or communication
* Receiving chemotherapy treatment
* Have had cardiovascular surgery in the last 3 months
* Those who have had myocardial infarction in the last 3 months
* Have had valve surgery in the last 6 months
* Have chronic obstructive pulmonary disease or asthma
* Chronic renal failure with glomerular filtration rate \< 30 ml/min
* Have a serious disease related to heart valves
* Piper fatigue scale score below 4
* Hb value below 8 gm/dL
* Existing Cardiac Resynchronization Therapy (CRT)
* Implantable Cardioverter Defibrillator (ICD) administered in the past 6 months
* Those who were informed about the research but did not want to participate in the research
In case of any of the above criteria, the patient is excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mustafa Kemal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Selva Ezgi Askar
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Selva Ezgi Aşkar
Role: PRINCIPAL_INVESTIGATOR
Mustafa Kemal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hatay Mustafa Kemal University Hospital
Hatay, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Degertekin M, Erol C, Ergene O, Tokgozoglu L, Aksoy M, Erol MK, Eren M, Sahin M, Eroglu E, Mutlu B, Kozan O. [Heart failure prevalence and predictors in Turkey: HAPPY study]. Turk Kardiyol Dern Ars. 2012 Jun;40(4):298-308. doi: 10.5543/tkda.2012.65031. Turkish.
Efe F., Olgun N. The Effect of Education on Dyspnea, Fatigue and Quality of Life in Patients with Heart Failure. Hacettepe University Faculty of Health Sciences Nursing Journal 2011; 1-13.
Ovayolu O. Ovayolu N. Evidence in Yoga Practices. HUHEMFAD-JOHUFON 2019; 6 (1): 44-49.
Grubic Kezele T, Babic M, Stimac D. Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals. Neurol Sci. 2019 Apr;40(4):733-743. doi: 10.1007/s10072-019-3707-0. Epub 2019 Jan 18.
Lopes CP, Danzmann LC, Moraes RS, Vieira PJC, Meurer FF, Soares DS, Chiappa G, Guimaraes LSP, Leitao SAT, Ribeiro JP, Biolo A. Yoga and breathing technique training in patients with heart failure and preserved ejection fraction: study protocol for a randomized clinical trial. Trials. 2018 Jul 28;19(1):405. doi: 10.1186/s13063-018-2802-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMKUASKAR-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.